Industrially relevant cell lines include both direct production hosts for recombinant proteins, vaccines and viral vectors, ...
Dublin, Nov. 20, 2026 (GLOBE NEWSWIRE) -- "CRISPR Cell Line Development Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The CRISPR cell line development market ...
Capitalize on biologics and biosimilar demand with AI, automation and CRISPR-enabled cell line development that improves yields and accelerates time-to-marketDublin, Nov. 16, 2026 (GLOBE NEWSWIRE) -- ...
Raman spectroscopy supports faster cell line development by reducing sampling requirements and improving clone screening ...
Asimov, the company building an AI-native synthetic biology platform to advance therapeutic development, and Emergent Biosolutions (NYSE: EBS), a leading global public health company, today announced ...
Cell line development is an essential step in the manufacture of biologics: drugs derived from living organisms, such as monoclonal antibodies, recombinant proteins and vaccines. In addition to this, ...
Cell line development is a crucial step in the drug discovery and development pipeline. It is essential in the manufacturing of biologics, as well as for drug screening, disease modeling and studying ...
Traditional approaches to biologics production—relying on one-size-fits-all expression vectors and empirical process optimization—have led to inefficiencies in expression, scalability, and ...
Induced pluripotent stem cell (iPSC)-derived therapies are rapidly gaining traction in the advanced therapeutics space, ...
Insourcing cell-line development has helped a fast-growing antibody manufacturer to deliver process improvements and strengthen communication with their contract manufacturer, according to Genmab, ...
The balancing act of ensuring the integrity and protection of a proprietary cell line development (CLD) process, data generated, and intellectual property (IP) while pursuing creation of a master cell ...
Cell line development continues to face technical and operational hurdles in transfection, clone selection, and media optimization. Manual screening, extended culture timelines, and fragmented data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results